Need Professional Help with Addiction?
Behavioral Health FAQs
Table of Contents
- How Common Is the Co-Occurrence of Addiction and Depression?
- Depression as a Driver of Addiction: The Self-Medication Pathway
- Addiction as a Driver of Depression: The Neurobiological Pathway
- Signs You May Be Dealing With Both Addiction and Depression
- The Danger of Treating Only One Condition
- How iRely Recovery Treats Addiction and Depression Together
- When to Seek Treatment
Key Points
- People with major depressive disorder are roughly twice as likely to develop a substance use disorder, and people in addiction treatment show rates of depression 4-5 times higher than the general population.
- Depression can drive addiction through self-medication — many people use alcohol, opioids, or stimulants to relieve depressive symptoms before tolerance and worsening depression trap them in a cycle.
- Addiction can also cause depression through dopamine receptor downregulation, HPA axis dysregulation, and chronic sleep disruption — anhedonia in early recovery is a neurobiological, not character, problem.
- Substance-induced depressive disorder is a recognized DSM-5 diagnosis where chronic use produces clinically significant depression that may persist weeks to months after last use.
- Standard addiction programs without integrated mental health care produce predictable relapse: after discharge, untreated depression makes sobriety feel unbearable.
- iRely Recovery's dual diagnosis program treats addiction and depression together from day one with psychiatric evaluation by a UCLA addiction psychiatrist, CBT, mindfulness-based therapy, and antidepressant medication when indicated.
One of the most common questions we hear at iRely Recovery is whether depression caused someone’s addiction, or whether the addiction caused the depression. For many of the clients we treat, the answer is both. What matters most is that both conditions are treated at the same time.
The relationship between addiction and depression is one of the most studied areas in addiction medicine. Understanding how these two conditions interact helps you recognize what is happening and make the case for comprehensive dual diagnosis treatment.
How Common Is the Co-Occurrence of Addiction and Depression?
Research shows that people with major depressive disorder are roughly twice as likely to develop a substance use disorder. People in addiction treatment show rates of depression four to five times higher than the general population.
Alcohol use disorder and major depressive disorder are among the most common co-occurring pairs. Treating one without the other dramatically increases the likelihood of relapse.
Depression as a Driver of Addiction: The Self-Medication Pathway
Depression is painful and relentless. When professional help is not available, many people turn to substances to manage the pain. Over time, the self-medication strategy stops working. The brain can no longer produce normal levels of neurotransmitters without the substance.
A person experiences chronic depression, often undiagnosed or untreated. They discover that alcohol, opioids, or stimulants temporarily relieve depressive symptoms. They use the substance more frequently as tolerance develops. Depressive symptoms worsen during periods of abstinence, reinforcing continued use.
Addiction as a Driver of Depression: The Neurobiological Pathway
Dopamine Depletion
Every addictive substance floods the brain with dopamine. Over time, the brain reduces dopamine receptor sensitivity. Natural rewards no longer register. The result is anhedonia, the inability to feel pleasure, which mirrors the experience of depression.
HPA Axis Dysregulation
Chronic substance use dysregulates the body’s central stress response system, contributing to chronically elevated cortisol levels that are strongly associated with depression.
Sleep Disruption
Almost all addictive substances disrupt normal sleep architecture. Chronic sleep disruption is one of the most potent triggers of depressive episodes, creating a direct pathway from substance use to clinical depression.
Signs You May Be Dealing With Both Addiction and Depression
Persistent low mood that does not improve even during periods of reduced use. Using substances specifically to feel normal rather than for pleasure. Complete loss of interest in once-enjoyable activities even when sober. Suicidal thoughts during periods of heavy use or early abstinence. Multiple failed attempts at sobriety that ended during periods of low mood.
The Danger of Treating Only One Condition
Standard addiction programs without integrated mental health care leave people in an impossible position. After residential treatment ends, untreated depression makes sobriety feel unbearable. The return to substances is not a character failure. It is a predictable response to unmanaged neurobiological pain.
How iRely Recovery Treats Addiction and Depression Together
Integrated Assessment From Day One
Every client at iRely Recovery undergoes a comprehensive biopsychosocial assessment that includes screening for depression and other co-occurring conditions.
Psychiatric Evaluation and Medication Management
Clients with significant depressive symptoms receive psychiatric evaluation by our consulting UCLA addiction psychiatrist. When antidepressant medication is appropriate, it is initiated with close monitoring.
Evidence-Based Therapies
Cognitive Behavioral Therapy (CBT) has the strongest evidence base for both depression and substance use disorder.
Mindfulness-Based approaches reduce the rumination that perpetuates depressive episodes and the emotional reactivity that triggers substance use.
Motivational Interviewing helps clients connect to reasons for recovery even when depression makes the future feel empty.
When to Seek Treatment
Do not wait for the depression to resolve before addressing the addiction. Both conditions need professional care at the same time.
iRely Recovery accepts most major insurance plans. Contact us at (818) 262-3537 or visit our admissions page to get started.
Frequently Asked Questions
Below are some of the most frequently asked questions regarding these two medications.
Sources
[1] National Institute on Drug Abuse. Common Comorbidities with Substance Use Disorders. NIDA Common Comorbidities
[2] Substance Abuse and Mental Health Services Administration. Co-Occurring Disorders. SAMHSA Co-Occurring Disorders
[3] U.S. Department of Labor. Mental Health Parity and Addiction Equity Act (MHPAEA). DOL MHPAEA
[4] American Society of Addiction Medicine. The ASAM Criteria. https://www.asam.org/asam-criteria
iRely Recovery Editorial Policy
When you choose to walk with us on your journey to recovery, you deserve information that lifts you up rather than weighs you down. Our Editorial Policy ensures that all content we produce is crafted to put clarity, credibility, and compassionate context in your hands. Resources are written by or in collaboration with industry professionals and receive additional medical review to ensure accuracy.
Read More About Our Process
